Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

P. Svenningsson; L. Berg; D. Matthews; D. F. Ionescu; E. M. Richards; M. J. Niciu; A. Malinger; M. Toups; H. Manji; M. H. Trivedi; C. A. Zarate; P. Greengard

ArticleOPEN ACCESS

Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

Molecular Psychiatry

DOI: 10.1038/mp.2014.13

33Citations

49Readers

Cite

CITATION STYLE

APA

Svenningsson, P., Berg, L., Matthews, D., Ionescu, D. F., Richards, E. M., Niciu, M. J., … Greengard, P. (2014, September 11). Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram. Molecular Psychiatry. Nature Publishing Group. https://doi.org/10.1038/mp.2014.13

Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

Cite

Register to see more suggestions